Nrf2-TERT-Acsl4 Pathway Inhibits Ferroptosis And Regulates Cytoskeletal Dynamics To Mitigate Ovarian Aging
Our bodies are constantly working to maintain health, and one crucial aspect for women is the health of their ovaries. As women age, ovarian function naturally declines, impacting fertility and overall well-being. Recent research sheds light on a fascinating cellular pathway that plays a significant role in this process.
At the heart of this discovery is a protective mechanism that combats a specific form of cell death called ferroptosis. Ferroptosis is essentially a type of cellular demise characterized by the accumulation of iron and damage to fats within the cell, which can accelerate aging in various tissues, including the ovaries. The pathway involves three key players: NRF2, TERT, and ACSL4.
NRF2 acts like a cellular superhero, activating the body’s natural antioxidant defenses to shield cells from harmful stress and prevent damage. On the other hand, ACSL4 is an enzyme that promotes the very lipid damage that leads to ferroptosis, essentially pushing cells towards this destructive fate. TERT, an enzyme known for its role in maintaining the protective caps on our chromosomes, also appears to be involved in how cells age and survive, likely influencing the overall health and structure of ovarian cells.
By understanding how this pathway works – with NRF2 inhibiting ferroptosis and ACSL4 promoting it, all while TERT influences cellular stability – scientists are gaining crucial insights into the fundamental processes of ovarian aging. This knowledge could pave the way for new strategies to maintain ovarian health and potentially extend reproductive longevity.
Source: link to paper